Clinical stage I nonseminoma: Surgery versus surveillance

Keyphrases

• Clinical Stage I 100%
• Retroperitoneal Lymph Node Dissection (RPLND) 100%
• Nonseminoma 100%
• Chemotherapy 66%
• Occult 66%
• Cure Rate 66%
• Treatment Options 33%
• Low Risk 33%
• Standard of Care 33%
• Testicle 33%
• Patient's Will 33%
• Adjuvant Therapy 33%
• Prognostic Factors 33%
• Combination Chemotherapy 33%
• Conventional Chemotherapy 33%
• Recurrent Disease 33%
• Orchiectomy 33%
• High-risk Population 33%
• Peritoneal Metastasis 33%
• Curative Intent 33%
• Premodern 33%
• Surgical Options 33%
• Non-seminomatous Germ Cell Tumor (NSGCT) 33%
• Relapse Risk 33%
• Primary Chemotherapy 33%
• Ultra-high Risk 33%
• Additional Therapy 33%
• New Biologics 33%
• Biologic Markers 33%

Medicine and Dentistry

• Clinical Stage 100%
• Retroperitoneal Lymph Node Dissection 100%
• Recurrent Disease 33%
• Combination Chemotherapy 33%
• Orchiectomy 33%
• Testes 33%
• High Risk Population 33%
• Adjuvant Therapy 33%
• Prognostic Factor 33%
• Non Seminomatous Germinoma 33%
• Retroperitoneal Disease 33%
• Retroperitoneal Cancer 33%